€960,135
▼ Sales (11 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Yen Kristen. Director active across 1 company, notably Soleno Therapeutics INC. In total, 17 reports have been published. Split: 0 buy · 11 sells. Total volume traded: €960k. History available since 26 May 2023. The latest transaction was disclosed on 21 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Yen Kristen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
10,400 shares0Common StockSEC:0001643441-26-000001:0
904 shares@ US$49.953.9% of flowCommon StockSEC:0001643441-25-000003:0
1,769 shares@ US$65.969111.3% of flowCommon StockSEC:0001415889-25-009297:0
6,400 shares0Common StockSEC:0001415889-25-001937:0
2,322 shares@ US$45.365610.6% of flowCommon StockSEC:0001415889-25-000956:0
2,789 shares@ US$49.335813.0% of flowCommon StockSEC:0001415889-24-024665:0
2,817 shares@ US$47.192612.4% of flowCommon StockSEC:0001415889-24-022651:0
2,826 shares@ US$45.476712.2% of flowCommon StockSEC:0001415889-24-020946:0
85,000 shares0Common StockSEC:0001415889-24-019810:0
473 shares@ US$41.22171.9% of flowCommon StockSEC:0001415889-24-019271:0
1,330 shares@ US$41.12275.3% of flowCommon StockSEC:0001415889-24-010250:0
397 shares@ US$48.301.8% of flowCommon StockSEC:0001415889-24-001929:0
24,000 shares0Common StockSEC:0001209191-24-001178:0
3,629 shares@ US$36.640212.9% of flowCommon StockSEC:0001209191-23-058705:0
3,963 shares@ US$28.651910.8% of flowCommon StockSEC:0001209191-23-057321:0
3,034 shares@ US$27.02627.8% of flowCommon StockSEC:0001209191-23-057037:0
29,131 shares0Common StockSEC:0001209191-23-032701:0
About Yen Kristen
Yen Kristen is a declarant linked to Soleno Therapeutics INC (XNAS), with the role listed as SEE REMARKS. Across 17 filings, the 17 sampled filings cover the period from 2023-05-26 to 2026-01-23 and show EUR 0 of purchases and EUR 960135 of sales, with Cession as the modal transaction nature.